Skip to content

GI Dynamics > Clinical-stage medical device company > New noninvasive approaches to treat obesity > Type 2 diabetes > Related metabolic diseases > EndoBarrier technology > EndoBarrier Gastrointestinal Liner > Orally delivered > Removable device > Lines portion of small intestine > Immediate metabolic control with less risk

Has GI Dynamics developed therapies resulting in weight loss and improved glycemic control? Is the technology designed to deliver immediate metabolic control by modifying metabolic pathways? Will EndoBarrier application data be presented at the 1st World Congress on Interventional Therapies for Type 2 Diabetes?

endobarrier.jpg

IIP > read on here > http://www.earthtimes.org…

Data from Clinical Trial of EndoBarrier(TM) Gastrointestinal Liner in Patients with Type 2 Diabetes to be Presented at the First World Congress on Interventional Therapies for Type 2 Diabetes in New York City

…GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to treat obesity and type 2 diabetes, will be presented at the First World Congress on Interventional Therapies for Type 2 Diabetes in New York City.

The session, entitled “Novel Gastrointestinal Interventional Therapies,” will be chaired by Lee M. Kaplan, M.D., Ph.D., associate professor of medicine and director of the Weight Center at Massachusetts General Hospital, on Tuesday, September 16, 2008 at 11:00 a.m. (EDT). Dr. Kaplan will present a keynote lecture “Endoluminal Therapies for Type 2 Diabetes” that will include new data from a prospective, randomized, sham-controlled clinical trial investigating the EndoBarrier Gastrointestinal Liner…

This was written by admin. Posted on Thursday, September 11, 2008, at . Filed under Corporate Acquisitions, Medical Ventures, Financing to Advance Commercialization, Expanded Portfolio, Three-way merger, Absorption of nutrients, First part of the small intestine, Obesity medicine, Obesity and diabetes, Obesity dragging down our health care system, Most effective treatment for obesity, Intestinal barrier device, Pre-commercial stage medical device companies, Alternative to Gastric Bypass, Pouch enlargement or dilatation of the gastrojejunostom, Patients Who Gain Weight After Bariatric Surgery, LAGB banding costs $17, Other bariatric weight loss operations cost $25, Diabetes is killing about 73, Natural Orifice Transgastric Endoscopic Surgery NOTES, Dmitry Nepomnayshy, Effect mimics gastric bypass, EndoBarrier Gastrointestinal Liner, Non-surgical alternative to gastric bypass, Route for resolving type 2 diabetes, Lahey Clinic, Natural Orifice Translumenal Endoscopic Surgery NOTES, Obesity is a complex condition, Weight Re-gain After Gastric Bypass, home by the day after surgery, Reduces Size of Stomach Pouch, Morbid obesity, Body mass index of greater than 50, Obesity, Treatment Of Obesity, Natural orifices such as the mouth rectum or vagina, Bodies' natural orifices, Risk factor obesity, Natural Orifice Transluminal Endoscopic Surgery NOTES, Body mass index, Surgical obesity intervention, Gastric bypass pouch and stoma reduction, Leak-proof closure, Natural Orifice Trans Umbilical Surgery NOTUS, Natural orifices tranlumenal endosurgery NOTES, natural orifice, Obesity Surgery, Laparoscopic Adjustable Gastric Banding LAGB, Metabolic disorder, Metabolic Diseases, Nutrition Disorders, Overweight, Overnutrition, Natural orifice transluminal endoscopic surgery. Bookmark the permalink. Follow comments here with the RSS feed. Both comments and trackbacks are currently closed.